Mendelian randomization study of sleep traits and risk of colorectal cancer
Language English Country England, Great Britain Media electronic
Document type Journal Article
Grant support
C18281/A29019
Cancer Research UK - United Kingdom
PubMed
40251235
PubMed Central
PMC12008275
DOI
10.1038/s41598-024-83693-w
PII: 10.1038/s41598-024-83693-w
Knihovny.cz E-resources
- MeSH
- Genome-Wide Association Study MeSH
- Circadian Rhythm genetics MeSH
- Genetic Predisposition to Disease MeSH
- Polymorphism, Single Nucleotide MeSH
- Colorectal Neoplasms * genetics epidemiology MeSH
- Humans MeSH
- Mendelian Randomization Analysis * MeSH
- Sleep Initiation and Maintenance Disorders genetics MeSH
- Risk Factors MeSH
- Sleep * genetics MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
A potential association of endogenous circadian rhythm disruption with risk of cancer development has been suggested, however, epidemiological evidence for the association of sleep traits with colorectal cancer (CRC) is limited and often contradictory. Here we investigated whether genetically predicted chronotype, insomnia and sleep duration are associated with CRC risk in males, females and overall and according to CRC anatomical subsites using Mendelian randomization (MR). The two-sample inverse variance weighted (IVW) method was applied using summary-level data in up to 58,221 CRC cases and 67,694 controls and genome-wide association data of genetic variants for self-reported sleep traits. Secondary analyses using alternative instruments and sensitivity analyses assessing potential violations of MR assumptions were conducted. Genetically predicted morning preference was associated with 13% lower risk of CRC in men (ORIVW = 0.87, 95% CI = 0.78, 0.97, P = 0.01), but not in women or in both sexes combined. Τhis association remained consistent in some, but not all, sensitivity analyses and was very similar for colon and rectal cancer. There was no evidence of an association for any other sleep trait. Overall, this study provides little to no evidence of an association between genetically predicted sleep traits and CRC risk.
Alvin J Siteman Cancer Center Washington University School of Medicine St Louis MO USA
Center for Cancer Research Medical University of Vienna Vienna Austria
CIBER Epidemiología y Salud Pública Madrid Spain
Department of Clinical Sciences Faculty of Medicine University of Barcelona Barcelona Spain
Department of Epidemiology Johns Hopkins Bloomberg School of Public Health Baltimore MD USA
Department of Epidemiology University of Washington Seattle WA USA
Department of Hygiene and Epidemiology University of Ioannina School of Medicine Ioannina Greece
Department of Laboratory Medicine and Pathology Mayo Clinic Arizona Scottsdale AZ USA
Department of Population Health Sciences Bristol Medical School University of Bristol Bristol UK
Division of Human Nutrition Wageningen University and Research Wageningen The Netherlands
Division of Preventive Oncology German Cancer Research Center Heidelberg Germany
Faculty of Medicine and Biomedical Center in Pilsen Charles University Pilsen Czech Republic
German Cancer Consortium Heidelberg Germany
Nutrition and Metabolism Branch International Agency for Research On Cancer WHO Lyon France
ONCOBEL Program Bellvitge Biomedical Research Institute L'Hospitalet de Llobregat Barcelona Spain
Population Science Department American Cancer Society Atlanta GA USA
Public Health Sciences Division Fred Hutchinson Cancer Research Center Seattle WA USA
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore MD USA
See more in PubMed
Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer J. Clin.71, 209–249 (2021). PubMed
IARC, I. A. of R. on C.-. NIGHT SHIFT WORK. IARC Monographs on the Identification of Carcinogenic Hazards to Humans Volume 124. vol. 124 (2020).
Chen, Y. et al. Sleep duration and the risk of cancer: A systematic review and meta-analysis including dose-response relationship. BMC Cancer18, 1–13 (2018). PubMed PMC
Lin, C. L., Liu, T. C., Wang, Y. N., Chung, C. H. & Chien, W. C. The association between sleep disorders and the risk of colorectal cancer in patients: A population-based nested case-control study. In Vivo (Brooklyn).33, 573–579 (2019). PubMed PMC
Jones, S. E. et al. Genome-wide association analyses of chronotype in 697,828 individuals provides insights into circadian rhythms. Nat. Commun.10, 343 (2019). PubMed PMC
Lane, J. M. et al. Biological and clinical insights from genetics of insomnia symptoms. Nat. Genet.19, 387–393 (2019). PubMed PMC
Jansen, P. R. et al. Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways. Nat. Genet.51, 394–403 (2019). PubMed
Dashti, H. S. et al. Genome-wide association study identifies genetic loci for self-reported habitual sleep duration supported by accelerometer-derived estimates. Nat. Commun.10, 1–12 (2019). PubMed PMC
Richmond, R. C. et al. Investigating causal relations between sleep traits and risk of breast cancer in women: Mendelian randomisation study. BMJ365, 1–12 (2019). PubMed PMC
Hayes, B. L. et al. Do sex hormones confound or mediate the effect of chronotype on breast and prostate cancer? A Mendelian randomization study. PLOS Genet.18, e1009887 (2022). PubMed PMC
Kyrgiou, M. et al. Adiposity and cancer at major anatomical sites: umbrella review of the literature. BMJ10.1136/bmj.j477 (2017). PubMed PMC
Pearson-Stuttard, J. et al. Type 2 diabetes and cancer: An umbrella review of observational and mendelian randomization studies. Cancer Epidemiol. Biomar. Prev.30, 1218–1228 (2021). PubMed PMC
Ma, Y. et al. Integrative identification of genetic loci jointly influencing diabetes-related traits and sleep traits of insomnia, sleep duration, and chronotypes. Biomedicines10, 368 (2022). PubMed PMC
Williams, J. A. et al. A causal web between chronotype and metabolic health traits. Genes (Basel).12, 1029 (2021). PubMed PMC
Lane, J. M. et al. Genome-wide association analysis identifies novel loci for chronotype in 100,420 individuals from the UK Biobank. Nat. Commun.7, 1–10 (2016). PubMed PMC
Titova, O. E. et al. Sleep duration and risk of overall and 22 site-specific cancers: A mendelian randomization study. Int. J. Cancer148, 914–920 (2021). PubMed PMC
Parent, M. É., El-Zein, M., Rousseau, M. C., Pintos, J. & Siemiatycki, J. Night work and the risk of cancer among men. Am. J. Epidemiol.176, 751–759 (2012). PubMed
Ahn, Y. S., Jeong, K. S. & Kim, K. S. Cancer morbidity of professional emergency responders in Korea. Am. J. Ind. Med.55, 768–778 (2012). PubMed
Tynes, T., Hannevik, M., Andersen, A. & Vistnes, A. I. Incidence female radio of breast and operators telegraph. Cancer Causes Control7, 197–204 (1996). PubMed
Papantoniou, K. et al. Rotating night shift work and colorectal cancer risk in the nurses’ health studies. Int. J. Cancer143, 2709–2717 (2018). PubMed PMC
Devore, E. E. et al. Rotating night shift work, sleep, and colorectal adenoma in women. Int. J. Colorectal Dis.32, 1013–1018 (2017). PubMed PMC
Lim, A. S. P. et al. Sex difference in daily rhythms of clock gene expression in the aged human cerebral cortex. J. Biol. Rhythms28, 117–129 (2013). PubMed PMC
Sudlow, C. et al. UK Biobank: An open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med.12, 1–10 (2015). PubMed PMC
Hu, Y. et al. GWAS of 89,283 individuals identifies genetic variants associated with self-reporting of being a morning person. Nat. Commun.7, 1–9 (2016). PubMed PMC
Krokstad, S. et al. Cohort profile: The HUNT study. Norway. Int. J. Epidemiol.42, 968–977 (2013). PubMed
Gainer, V. S. et al. The biobank portal for partners personalized medicine: A query tool for working with consented biobank samples, genotypes, and phenotypes using i2b2. J. Pers. Med.6, 11 (2016). PubMed PMC
Gottlieb, D. J. et al. Novel loci associated with usual sleep duration: The CHARGE consortium genome-wide association study. Mol. Psychiatr.20, 1232–1239 (2015). PubMed PMC
Burgess, S. & Thompson, S. G. Avoiding bias from weak instruments in mendelian randomization studies. Int. J. Epidemiol.40, 755–764 (2011). PubMed
Das, S. et al. Next-generation genotype imputation service and methods. Nat. Genet.48, 1284–1287 (2016). PubMed PMC
Delaneau, O., Howie, B., Cox, A. J., Zagury, J. F. & Marchini, J. Haplotype estimation using sequencing reads. Am. J. Hum. Genet.93, 687–696 (2013). PubMed PMC
McCarthy, S. et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat. Genet.48, 1279–1283 (2016). PubMed PMC
Brion, M. J. A., Shakhbazov, K. & Visscher, P. M. Calculating statistical power in mendelian randomization studies. Int. J. Epidemiol.42, 1497–1501 (2013). PubMed PMC
Hartwig, F. P., Davies, N. M., Hemani, G. & Davey Smith, G. Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique. Int. J. Epidemiol.45, 1717–1726 (2016). PubMed PMC
Burgess, S., Butterworth, A. & Thompson, S. G. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol.37, 658–665 (2013). PubMed PMC
Bowden, J. et al. A framework for the investigation of pleiotropy in two-sample summary data mendelian randomization. Stat. Med.36, 1783–1802 (2017). PubMed PMC
Hemani, G. et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife7, 1–29 (2018). PubMed PMC
Lawlor, D. A., Harbord, R. M., Sterne, J. A. C., Timpson, N. & Davey Smith, G. Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology. Stat. Med.27, 1133–1163 (2008). PubMed
Staiger, D. & Stock, J. H. Instrumental variables regression with weak instruments. Econometrica65, 557 (1997).
Bowden, J., Smith, G. D. & Burgess, S. Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression. Int. J. Epidemiol.44, 512–525 (2015). PubMed PMC
Bowden, J. et al. Assessing the suitability of summary data for two-sample mendelian randomization analyses using MR-Egger regression: The role of the I 2 statistic. Int. J. Epidemiol.45, 1961–1974 (2016). PubMed PMC
Bowden, J., Davey Smith, G., Haycock, P. C. & Burgess, S. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet. Epidemiol.40, 304–314 (2016). PubMed PMC
Hartwig, F. P., Smith, G. D. & Bowden, J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int. J. Epidemiol.46, 1985–1998 (2017). PubMed PMC
Burgess, S., Foley, C. N., Allara, E., Staley, J. R. & Howson, J. M. A robust and efficient method for Mendelian randomization with hundreds of genetic variants: unravelling mechanisms linking HDL-cholesterol and coronary heart disease. BioRxiv10.1101/566851 (2019).
Verbanck, M., Chen, C. Y., Neale, B. & Do, R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet.50, 693–698 (2018). PubMed PMC
Yavorska, O. O. & Burgess, S. MendelianRandomization: An R package for performing mendelian randomization analyses using summarized data. Int. J. Epidemiol.46, 1734–1739 (2017). PubMed PMC
Jones, S. E. et al. Genetic studies of accelerometer-based sleep measures yield new insights into human sleep behaviour. Nat. Commun.10, 1–12 (2019). PubMed PMC
Burgess, S. & Thompson, S. G. Multivariable mendelian randomization: The use of pleiotropic genetic variants to estimate causal effects. Am. J. Epidemiol.181, 251–260 (2015). PubMed PMC
Sanderson, E., Spiller, W. & Bowden, J. Testing and correcting for weak and pleiotropic instruments in two-sample multivariable mendelian randomisation. BioRxiv10.1101/2020.04.02.021980 (2020). PubMed PMC
Sanderson, E., Davey Smith, G., Windmeijer, F. & Bowden, J. An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings. Int. J. Epidemiol.48, 713–727 (2019). PubMed PMC
Straif, K. et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol.8, 1065–1066 (2007). PubMed
Schernhammer, E. S. et al. Night-shift work and risk of colorectal cancer in the Nurses’ Health Study. J. Natl. Cancer Inst.95, 825–828 (2003). PubMed
Vetter, C. et al. Mismatch of sleep and work timing and risk of type 2 diabetes. Diabetes Care38, 1707–1713 (2015). PubMed PMC
United States Department of Labor. Workers on flexible and shift schedule in May 2004. 1–16 (2005).
Cain, S. W. et al. Sex differences in phase angle of entrainment and melatonin amplitude in humans. J. Biol. Rhythms25, 288–296 (2010). PubMed PMC
Hurley, S., Goldberg, D., Bernstein, L. & Reynolds, P. Sleep duration and cancer risk in women. Cancer Causes Control26, 1037–1045 (2015). PubMed PMC
Gu, F. et al. Sleep duration and cancer in the NIH-AARP diet and health study cohort. PLoS One11, 1–14 (2016). PubMed PMC
Lin, Y. et al. Associations of dinner-to-bed time, post-dinner walk and sleep duration with colorectal cancer A case-control study. Med. (United States)97, 1–7 (2018). PubMed PMC
Thompson, C. L. et al. Short duration of sleep increases risk of colorectal adenoma. Cancer117, 841–847 (2011). PubMed PMC
Papantoniou, K. et al. Sleep duration and napping in relation to colorectal and gastric cancer in the MCC-Spain study. Sci. Rep.11, 1–14 (2021). PubMed PMC
Jiao, L. et al. Sleep duration and incidence of colorectal cancer in postmenopausal women. Br. J. Cancer108, 213–221 (2013). PubMed PMC
Zhang, X. et al. Associations of Self-Reported Sleep Duration and Snoring with Colorectal Cancer Risk in Men and Women. Sleep36, 681–688 (2013). PubMed PMC
Lauderdale, D. S., Knutson, K. L., Yan, L. L., Liu, K. & Rathouz, P. J. Self-reported and measured sleep duration: How similar are they?. Epidemiology19, 838–845 (2008). PubMed PMC
Burgess, S., Davies, N. M. & Thompson, S. G. Bias due to participant overlap in two-sample mendelian randomization. Genet. Epidemiol.40, 597–608 (2016). PubMed PMC